Novartis (NVS) Reports FDA Approval of Jadenu Tablets
Tweet Send to a Friend
Novartis (NYSE: NVS) announced today that the US Food and Drug Administration (FDA) has approved JadenuTM (deferasirox) tablets, a new ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE